MedPark is a specialized regenerative medicine company, dedicated to serving as a solution provider for overall bodily regeneration, including bone, skin, and organ. MedPark holds over 80 patents spanning from bone to skin regeneration and maintains certifications US FDA and European CE. We’ve commercialized products from animal to synthetic origins and aim to lead Asia-Pacific’s regenerative medicine sector with a 2025 IPO.
Event
[Seminar]
One Day Seminar in Taiwan
This March, we successfully held a hands-on seminar workshop in Taiwan to introduce S1 to many people. We will continue to provide various events so that many people can experience.
[Exhibition]
KSES 2024 MedPark participated in The 31st Annual International Congress of Korean Shoulder and Elbow Society with great success. Many people visited our booth and we had the opportunity to introduce our unique medical products. We are planning to participate in various exhibitions in the future. Thank you
[Exhibition]
APS 2024
4/6~4/7 the 2024 Aesthetic Plastic Surgery Congress was held for two days! It was a great opportunity to showcase MedPark’s aesthetic products to many people who visited the conference. Stay tuned for the next congress to learn more about MedParkʻs innovative technologies :)
[Exhibition]
OBGY 2024
MedPark successfully participated in OBGY2024. We sincerely thank everyone who visited the MedPark booth. We will be happy to assist you with any information you may need. See you again.
News
MedPark Headquarters Renovation
MedPark is driving innovation and improvement across its laboratories, factories, and headquarters offices. We're leveraging cutting-edge equipment and technology to support research and production activities, while also fostering an environment where team members can collaborate creatively. We remain committed to ongoing development efforts.
Products
BOSS - Similar porosity to human bone - Biocompatibility - Excellent Pore Structure - Easy Manipulation
